In CD8 + T cells, JHU-083 suppresses glutamine metabolism and glycolysis but upregulates OXPHOS, utilizing extracellular acetate as an alternative fuel to potentiate its anti-tumor effects [15]. Here, CD8A is linked to neoplasm.